Akebia Therapeutics (AKBA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist

1.2100
+0.1000+9.01%

Trading Aug 8 13:44 ET

254.45MMarket Cap-5761P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Akebia Therapeutics | 10-Q: Quarterly report
SEC announcementAug 8 07:54 ET · Announcements
Earnings Flash (AKBA) AKEBIA THERAPEUTICS Posts Q2 Revenue $43.6M, Vs. Street Est of $43.7M
MT NewswiresAug 8 07:23 ET
Akebia Therapeutics Q2 2024 GAAP EPS $(0.04) Beats $(0.05) Estimate, Sales $43.648M Miss $49.450M Estimate
BenzingaAug 8 07:16 ET
Express News | Akebia Therapeutics Q2 Operating Income USD -8.725 Million
ReutersAug 8 07:00 ET
Express News | Akebia Therapeutics Q2 Net Income USD -8.582 Million
ReutersAug 8 07:00 ET
Express News | Akebia Therapeutics Q2 Basic EPS USD -0.04
ReutersAug 8 07:00 ET

Comments

101674396

Yesterday 01:18

$Akebia Therapeutics (AKBA.US)$ ..what happened??

101674396

Jul 24 10:46

$Akebia Therapeutics (AKBA.US)$ … slowly will reach to 1.7 to 1.8

Trytosaveabit

Jul 11 14:55

LIKE!

$Akebia Therapeutics (AKBA.US)$ The PR actually gave this a fairly nice profit opportunity today

Trytosaveabit

Jul 11 05:05

Update

$Akebia Therapeutics (AKBA.US)$ Reuters 2 mins ago Akebia Regains Full Rights to Sell Vafseo Tablets in U.S. Following Execution of a Royalty-Based Termination Agreement With CSL Akebia Therapeutics Inc: Regains Full Rights to Sell Vafseo® (Vadadustat) Tablets in U.S. Akebia Therapeutics Inc -Announced Vafseo Wac Pricing of $1,278 for a 30-Day Supply Akebia Therapeutics Inc: Submitted Tdapa Application for Vafseo in June 2024 and Expects Designation on January 1, 2025

momoAbdul

May 21 11:20

$Akebia Therapeutics (AKBA.US)$ any reason why this stock is underperforming?

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

AKBA Akebia Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target